
News from endpoints.news
Top endpoints.news News

Novo Nordisk · DenmarkNovo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity drug, with lower growth expected for its treatments in the second half of the year. The drugmaker, which was Europe's most valuable company worth some $650 billion last year on the back of sales of its blockbuster weight-loss drug, is facing a pivotal moment as competition intensifies.See the Story
Wegovy maker Novo Nordisk to cut costs as weight-loss competition heats up
44% Left coverage: 9 sources